The JCSO Interview

New myeloma drugs improve response and extend survival

An interview series in which Editors of The Journal of Community and Supportive Oncology discuss the latest research and best practices with experts in the clinical and supportive care of patients with cancer.

Submit a paper here


In this interview, Dr David Henry, the Editor-in-Chief of The Journal of Community and Supportive Oncology, and Dr Ken Anderson, the Kraft Family Professor of Medicine at Harvard Medical School and an international thought leader and investigator in myeloma, discuss three cases of patients with myeloma that are indicative of the remarkable therapeutic advances in oncology in general, and in myeloma in particular.

Listen to the podcast below

Next Article: